Benzinga's Top Initiations

Analysts at Guggenheim Securities initiated coverage on shares of Celldex Therapeutics

with a “buy” rating. The target price for Celldex Therapeutics is set to $24. Celldex's shares closed at $18.37 yesterday. Stephens & Co initiated coverage on shares of GATX

with an “overweight” rating. The target price for GATX is set to $50. GATX's shares closed at $46.66 yesterday. Needham initiated coverage on shares of 21st Century Fox

with a “buy” rating. The target price for 21st Century Fox is set to $46. 21st Century Fox's stock closed at $29.21 yesterday. Analysts at Bank of America initiated coverage on shares of Martin Midstream Partners LP

with a “neutral” rating. The target price for Martin Midstream Partners is set to $47. Martin Midstream's shares closed at $44.82 yesterday.